# Pulmonary Arterial studies recruiting: 42 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 42 trials that are observational for Pulmonary Arterial Hypertension that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational Pulmonary Arterial Hypertension studies: 42 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/pulmonary-arterial-hypertension

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 42
- Recruiting or not yet: 42
- Read on: November 19, 2026

## Trials

The 25 newest of 42, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 17, 2026 | NCT07942012 | PHORA-USE Registry (PHORAR) | Sentara Norfolk General Hospital | Observational | Not yet recruiting | Pulmonary Arterial Hypertension | 650 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07942012) |
| October 22, 2026 | NCT07890285 | A Study of Opsynvi in Adults Participants With Pulmonary Arterial Hypertension in Korea | Janssen Korea, Ltd., Korea | Observational | Not yet recruiting | Pulmonary Arterial Hypertension | 333 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07890285) |
| October 1, 2026 | NCT07852403 | PAH-SDB: Sleep-Disordered Breathing and Outcomes in Pulmonary Arterial Hypertension | Chinese Pulmonary Vascular Disease Research Group | Observational | Recruiting | Pulmonary Arterial Hypertension (PAH), Sleep-disordered Breathing (SDB) | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07852403) |
| August 17, 2026 | NCT07768644 | Nailfold Capillaroscopy in PH | University of Glasgow | Observational | Recruiting | Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH), Pulmonary Hypertension (World Health Organization Group 3)... | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07768644) |
| July 30, 2026 | NCT07736846 | TREPROSTINIL in Pulmonary Hypertension: Evidence and Clinical Trends | AOP Orphan Pharmaceuticals AG | Observational | Not yet recruiting | Pulmonary Arterial Hypertension (PAH) | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07736846) |
| May 6, 2026 | NCT07570615 | Development and Validation of a Chinese Quality of Life Scale for Pulmonary Arterial Hypertension | Chinese Pulmonary Vascular Disease Research Group | Observational | Not yet recruiting | Pulmonary Arterial Hypertension (PAH), Quality of Life, Patients Reported Outcomes | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07570615) |
| March 23, 2026 | NCT07487441 | Reverse Remodeling of the Pulmonary Vasculature: a Longitudinal, Investigational Study of the Effects of Sotatercept. | Sponsor not shown (see the record) | Observational | Not yet recruiting | Pulmonary Arterial Hypertension (PAH), Pulmonary Hypertension | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07487441) |
| March 5, 2026 | NCT07453030 | Long-Term Outcomes of Selexipag in Schistosomiasis-Associated Pulmonary Arterial Hypertension | Sponsor not shown (see the record) | Observational | Not yet recruiting | Pulmonary Arterial Hypertension (PAH) | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07453030) |
| January 28, 2026 | NCT07374302 | Riociguat in Triple Therapy for Pulmonary Arterial Hypertension in Real-World Practice | Sponsor not shown (see the record) | Observational | Not yet recruiting | Pulmonary Arterial Hypertension | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07374302) |
| January 21, 2026 | NCT07356375 | Patient-Reported Outcomes and Adherence After Transition From Inhaled Iloprost to Oral Selexipag in Pulmonary Arterial Hypertension | University of Sao Paulo General Hospital | Observational | Not yet recruiting | Pulmonary Arterial Hypertension (PAH) | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07356375) |
| January 2, 2026 | NCT07314814 | Genetic Hallmarks of Patients With Congenital Portosystemic Shunts and Portopulmonary Hypertension | Sponsor not shown (see the record) | Observational | Not yet recruiting | Portopulmonary Hypertension, Pulmonary Arterial Hypertension (PAH), Congenital Portosystemic Shunt | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07314814) |
| December 31, 2025 | NCT07312227 | A Prospective Longitudinal Observational Cohort Study of Pregnant Women Residing at High Altitude in Bolivia | Massachusetts General Hospital | Observational | Recruiting | Hypertensive Disorder of Pregnancy, Pulmonary Arterial Hypertension, Intrauterine Growth Restriction | 27 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07312227) |
| October 16, 2025 | NCT07217522 | Rutgers University Study of the Genetics of Pulmonary Hypertension | Rutgers, The State University of New Jersey | Observational | Recruiting | Pulmonary Hypertension, Pulmonary Arterial Hypertension, Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)... | 10,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07217522) |
| October 6, 2025 | NCT07207525 | Information Sources in Pulmonary Hypertension | University of Sao Paulo General Hospital | Observational | Not yet recruiting | Pulmonary Arterial Hypertension (PAH) | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07207525) |
| September 16, 2025 | NCT07176260 | Exploring Blood Cell Function and Oxidative Stress to Improve Diagnosis and Treatment in Pre-Capillary Pulmonary Hypertension | University Hospital, Strasbourg, France | Observational | Recruiting | Pre-capillary Pulmonary Hypertension | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07176260) |
| September 15, 2025 | NCT07172334 | What is the Role of the Exposome in Pulmonary Hypertension | Poitiers University Hospital | Observational | Not yet recruiting | Pulmonary Arterial Hypertension (PAH), Chronic Thromboembolic Pulmonary Hypertension (CTEPH) | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07172334) |
| August 22, 2025 | NCT07137260 | Digital Assessment of Real-World Walking Activity in Pulmonary Hypertension: A Prospective Multicenter Trial | Sponsor not shown (see the record) | Observational | Recruiting | Pulmonary Hypertension, Precapillary Pulmonary Hypertension, Right Heart Catheterisation, Digital Mobility Outcomes | 77 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07137260) |
| July 24, 2025 | NCT07082933 | Long-term Survival and Influencing Factors of Patients With Pulmonary Arterial Hypertension and Diabetes | Xijing Hospital | Observational | Not yet recruiting | Pulmonary Arterial Hypertension (PAH) | 5,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07082933) |
| June 26, 2025 | NCT07039604 | Real-World Study of PADN for the Treatment of PAH | Pulnovo Medical (Wuxi) Co., Ltd. | Observational | Recruiting | Pulmonary Hypertension, Hypertension, Pulmonary Arterial | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07039604) |
| June 10, 2025 | NCT07013149 | The Impact of ERA Switching on Risk Stratification in Pulmonary Arterial Hypertension | University of Sao Paulo General Hospital | Observational | Recruiting | Pulmonary Arterial Hypertension, Pulmonary Arterial Hypertension (PAH), Pulmonary Arterial Hypertension (PAH) (WHO... | 183 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07013149) |
| May 31, 2025 | NCT06998329 | PulmonAry hyperteNsion DiagnOsis: a National cohoRt reseArch | University of Sao Paulo General Hospital | Observational | Recruiting | Pulmonary Arterial Hypertension (PAH), Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH), Pulmonary Arterial... | 139 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06998329) |
| May 2, 2025 | NCT06954727 | China Pulmonary Vascular Disease Intervention Diagnosis and Management Study-right Heart Catheterization | China-Japan Friendship Hospital | Observational | Recruiting | Pulmonary Hypertension, Pulmonary Embolism (Diagnosis), Pulmonary Arterial Hypertension, Right Heart Catheterization | 10,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06954727) |
| April 11, 2025 | NCT06923917 | European Registry of Acutely Decompensated Pulmonary Arterial Hypertension | Assistance Publique - Hôpitaux de Paris | Observational | Not yet recruiting | Pulmonary Hypertension | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06923917) |
| April 8, 2025 | NCT06917196 | PROOF OF CONCEPT STUDY ON THE EFFICACY OF INHALATORY TARGETED IMATINIB NANOFORMULATIONS IN PULMONARY HYPERTENSION AND POST-INFLAMMATORY... | Fondazione IRCCS Policlinico San Matteo di Pavia | Observational | Recruiting | Pulmonary Arterial Hypertension (PAH), Lung Fibrosis Interstitial | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06917196) |
| March 7, 2025 | NCT06865118 | Home-Based Clinical Management of Cardiac Complications in Systemic Sclerosis | Oslo University Hospital | Observational | Recruiting | Systemic Sclerosis (SSc), Pulmonary Arterial Hypertension (PAH), Home Monitoring Follow-up | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06865118) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Chinese Pulmonary Vascular Disease Research Group | 4 |
| University of Sao Paulo General Hospital | 4 |
| University Hospital, Strasbourg, France | 1 |
| New York Medical College | 1 |
| Duke University | 1 |
| Sentara Norfolk General Hospital | 1 |
| AOP Orphan Pharmaceuticals AG | 1 |
| Massachusetts General Hospital | 1 |
| Oslo University Hospital | 1 |
| Qianfoshan Hospital | 1 |
| Vanderbilt University Medical Center | 1 |
| Nanjing First Hospital, Nanjing Medical University | 1 |
| Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 1 |
| Taichung Veterans General Hospital | 1 |
| ChromX Health | 1 |
| Technische Universität Dresden | 1 |
| Gazi University | 1 |
| Rutgers, The State University of New Jersey | 1 |
| Polish Cardiology Association | 1 |
| Poitiers University Hospital | 1 |
| Xijing Hospital | 1 |
| Excelsior | 1 |
| Fondazione IRCCS Policlinico San Matteo di Pavia | 1 |
| University of Glasgow | 1 |
| Pulmonary Hypertension Association, Inc. | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 9 |
| China | 8 |
| Brazil | 4 |
| France | 3 |
| Canada | 2 |
| Germany | 2 |
| Italy | 2 |
| Switzerland | 2 |
| Bolivia | 1 |
| Norway | 1 |
| Mexico | 1 |
| Taiwan | 1 |
| Belgium | 1 |
| Turkey (Türkiye) | 1 |
| Poland | 1 |
| United Kingdom | 1 |
| Argentina | 1 |
| South Korea | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Propane suppliers in the United States](https://specstream.ai/data/businesses/propane-suppliers/united-states)
- [Podiatrists in the United States](https://specstream.ai/data/businesses/podiatrists/united-states)
- [Pediatric neurology practices in the United States](https://specstream.ai/data/businesses/pediatric-neurology-practices/united-states)
- [Otology practices in the United States](https://specstream.ai/data/businesses/otology-practices/united-states)
- [Neuropathology practices in the United States](https://specstream.ai/data/businesses/neuropathology-practices/united-states)
- [Metal fabricators in the United States](https://specstream.ai/data/businesses/metal-fabricators/united-states)
